Key result
Malondialdehyde levels on postoperative day 1 independently predicted postoperative cognitive dysfunction in elderly patients after hip fracture surgery (OR 1.12; 95% CI 1.03-1.23; P=0.017).
Why the study?
Postoperative cognitive dysfunction is a major issue associated with poor outcomes, prompting exploration of promising predictors in elderly patients after hip fracture surgery.
Does malondialdehyde on postoperative day 1 predict postoperative cognitive dysfunction in elderly patients after hip fracture surgery?
Observational (n=198)
Does malondialdehyde on postoperative day 1 predict postoperative cognitive dysfunction in elderly patients after hip fracture surgery?
Malondialdehyde levels on postoperative day 1 may serve as a predictor for postoperative cognitive dysfunction in elderly patients undergoing hip fracture surgery.
Answers are grounded in this paper and cite their sources.
MDA on POD1 may flag POCD risk in elderly hip fracture patients; hypothesis-generating and requires prospective validation before clinical use.
Background: Postoperative cognitive dysfunction (POCD) is a great problem for anesthetized subjects and is associated with poor short- and long-term outcomes. We explored promising predictors for POCD in elderly patients after hip fracture surgery. Methods: Elderly subjects (aged ≥65 years) undergoing surgery for hip fracture were consecutively recruited. Neuropsychological assessments were performed 1 day preoperatively (baseline) and 7 days postoperatively, and POCD was defined using the ‘Z scores’ method. Clinical data and laboratory tests were compared between patients with and without POCD development. Binary univariate and multivariate logistic regression analyses were conducted for risk factor assessment. Receiver operating characteristic (ROC) curve analysis was performed to investigate the predictive value of malondialdehyde (MDA) on postoperative day 1 (POD1) for POCD. Results: A total of 198 patients were finally enrolled in the analysis and 51 patients exhibited POCD within 7 postoperative days, with an incidence rate of 25.8%. MDA expression on POD1 (OR: 1.12, 95%CI: 1.03–1.23, P=0.017) was the only independent risk factor for POCD according to the final multivariate logistic regression analysis. ROC curve analysis indicated that MDA on POD1 was a predictor for POCD, with an area under the curve (AUC) of 0.683 and 95%CI of 0.590–0.775 (P<0.001). Conclusions: In conclusion, we demonstrated that MDA on POD1 was an independent risk factor for POCD in elderly subjects undergoing hip fracture surgery.
No takes yet. Share an insight, caveat, or question.
Chun-xian et al. (2019) conducted an observational in hip fracture surgery (n=198). Malondialdehyde (MDA) on postoperative day 1 was evaluated on Postoperative cognitive dysfunction (POCD) (OR 1.12, 95% CI 1.03-1.23, p=0.017). Malondialdehyde levels on postoperative day 1 independently predicted postoperative cognitive dysfunction in elderly patients after hip fracture surgery (OR 1.12; 95% CI 1.03-1.23; P=0.017).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: